Bloomberg News

Navamedic Rises on ‘Successful Launch’ of Two Generic Drugs

October 12, 2011

Oct. 12 (Bloomberg) -- Navamedic ASA jumped in Oslo after the Norwegian pharmaceutical products company announced the “successful launch” of its two first generic pharmaceutical products.

The shares rose 1.3 kroner, or 9.5 percent, to 15 kroner as of 9:09 a.m. local time.

To contact the editor responsible for this story: Meera Bhatia at mbhatia2@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus